ANG Lifesciences Quarterly Results for Trading Insights
ANG • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-3 Cr
QSept 2025
ANG Lifesciences Quarterly Results Key Highlights
- Revenue of ₹26 Cr in Sept 2025 (+44.4% vs Mar 2025, -21.2% vs Sept 2024)
- Net Profit of ₹-3 Cr in Sept 2025 (-50.0% vs Mar 2025, -50.0% vs Sept 2024)
- Earnings Per Share of ₹-2.24 in Sept 2025 (-43.6% vs Mar 2025)
ANG Lifesciences Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 26 | 18 | 25 | 33 | 38 | 44.4% | -21.2% |
| Net Profit (₹ Cr) | -3 | -2 | -2 | -2 | -4 | - | - |
| EBITDA (₹ Cr) | 0 | 0 | 1 | 3 | 2 | - | - |
| EPS (₹) | -2.24 | -1.56 | -1.52 | -1.53 | -2.75 | - | - |
| Operating Margin (%) | 0.0% | -4.0% | 3.0% | 7.0% | 4.0% | - | - |
ANG Lifesciences Share Price Trend Around Quarterly Results
Visualize ANG Lifesciences's 1-year price movement across quarterly results — ideal for logging trades in ANG Lifesciences share price
chart using Tickjournal. All values in ₹.
Related Pages for ANG Lifesciences
Additional stock information and data for ANG
Revenue Trend (₹ Cr)
Sept 2024
33
Jun 2025
25
Mar 2025
18
Sept 2025
26
Net Profit Trend (₹ Cr)
Sept 2024
-2
Jun 2025
-2
Mar 2025
-2
Sept 2025
-3
Operating Margin Trend (%)
Sept 2024
7.0%
Jun 2025
3.0%
Mar 2025
-4.0%
Sept 2025
0.0%
Sector Competitors - Quarterly Performance Comparison
Comparing ANG Lifesciences quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores